Skip to content

Jerash Holdings (US), Inc. JRSH Interest Expense, Nonoperating

Interest Expense, Nonoperating at other companies

CTO
Citius Oncology, Inc.CTOR
$33.03K
Spectral AI, Inc. logo
Spectral AI, Inc.MDAI
$258K+1,190%
XTI Aerospace, Inc. logo
XTI Aerospace, Inc.XTIA
$154K-29.0%
Cal-Maine Foods logo
Cal-Maine FoodsCALM
$153K+11.5%
Dakota Gold logo
Dakota GoldDC
$34.37K
Evommune
 logo
Evommune EVMN
$25.8K-72.9%

Other financials

Income statement

See full
Revenue$41.8M+18.0%
Gross profit$7.0M+31.0%
Operating income$1.9M+175%
Net income$1.2M+20,261%
EPS (diluted)$0.09

Balance sheet

See full
Cash & equivalents$11.5M-22.5%
Total debt$365.0K-45.5%
Total equity$63.6M+0.7%
Total assets$84.2M+5.5%

Cash flow

See full
Operating cash flow-$3.8M-26.7%
CapEx$92.0K-35.8%
Free cash flow-$3.9M-23.8%

Valuation

See full
Market cap$61.09M+36.1%
Enterprise value$50M+25.3%
P/E34×-21.1×
P/S0.4×+0.1×

Profitability

See full
Gross margin16.2%+2.7pp
Operating margin2.9%+2.2pp
Net margin1.2%+0.7pp
FCF margin-2.9%

Returns & leverage

See full
Return on equity2.8%+1.7pp
Debt / equity0.0×
Current ratio2.8×-0.3×

Where this comes from

Reported directly by Jerash Holdings (US), Inc. in its filing.

Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.

The official record: Jerash Holdings (US), Inc.’s 10-Q, filed February 10, 2026, on SEC EDGAR. View the filing →

Ask your AI about Jerash Holdings (US), Inc.'s interest expense, nonoperating.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Jerash Holdings (US), Inc.'s interest expense, nonoperating?
Jerash Holdings (US), Inc. (JRSH) reported interest expense, nonoperating of $393.19K in Q4 2025.
How has Jerash Holdings (US), Inc.'s interest expense, nonoperating changed year-over-year?
Jerash Holdings (US), Inc.'s interest expense, nonoperating increased by 7.7% year-over-year, from $364.94K to $393.19K.
What does interest expense, nonoperating mean?
Represents the cost incurred by an entity in connection with the borrowing of funds, excluding interest related to operating leases or other specific activities. High levels of this expense relative to operating income may indicate significant financial leverage and risk.